课题基金 / 基金详情

Accelerating Inflammation Resolution to CounterACT Chemical Injury

Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
批准号:
8900466
负责人:
SVEN-ERIC JORDT
金额:
$22.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-19 至 2015-08-31

项目摘要

项目成果

SVEN-ERIC JORDT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Exposures to chemical threat agents oftentimes induce strong inflammatory tissue responses that contribute to morbidity and prevent tissue repair and recovery. Pulmonary exposures to chlorine trigger a potent inflammatory response resulting in vascular leakage, cardiopulmonary depression, neutrophil infiltration and a pulmonary and systemic hypercytokinemia comparable to the cytokine storm observed in sepsis. Similar inflammatory responses are observed after inhalation exposures to phosgene and acidic (HCl) or alkaline gases (ammonia) and reactive industrial chemicals such as acrolein, and to riot control agents (CS, CN or CR), and following cutaneous exposures to vesicants. Classical anti-inflammatory treatments against chemical injury have focused on interference with target pathways involved in the initiation and maintenance of inflammation. These strategies have only been partially successful, due to the large variety of pathways and pathologies involved. The inflammatory response is divided into three temporal phases, initiation, amplification and maintenance, and resolution. A new area of inflammation research has focused on the process of inflammation resolution, an active mechanism involving the activation of signaling pathways during inflammation initiation, and the later generation of omega 3 fatty-acid derived inflammation-resolving mediators that activate resolution mechanisms. In our preliminary studies we observe that post exposure treatment with Resolvin D1, an inflammation-resolving agent, strongly inhibited skin edema formation and inflammation in mice exposed to the vesicant, CEES, and the electrophilic riot control agent, CS. Our proposed studies are designed to 1: Examine the effects of inflammation-resolving agents in mouse models of cutaneous exposures to vesicants and electrophilic chemical threats and, 2: Study the effects of inflammation-resolving agents on pulmonary injury progression in mice exposed to chlorine and HCl.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nicotine Pouches: Chemical Composition, Toxicity and Behavioral Effects of a New Tobacco Product Category
  • 批准号:
    10673370
  • 项目类别:
  • 资助金额:
    $41.65万
  • 财政年份:
    2022
  • 负责人:
    SVEN-ERIC JORDT
  • 依托单位:
Molecular Core
  • 批准号:
    9703532
  • 项目类别:
  • 资助金额:
    $31.23万
  • 财政年份:
    2020
  • 负责人:
    SVEN-ERIC JORDT
  • 依托单位:
Anesthetic and synthetic cooling flavors in E-cigarettes: Chemistry and respiratory effects modulating nicotine intake
  • 批准号:
    9982329
  • 项目类别:
  • 资助金额:
    $47.35万
  • 财政年份:
    2018
  • 负责人:
    SVEN-ERIC JORDT
  • 依托单位:
Mechanisms of Itch in Poison Ivy-Induced Allergic Contact Dermatitis
  • 批准号:
    9164682
  • 项目类别:
  • 资助金额:
    $20.99万
  • 财政年份:
    2016
  • 负责人:
    SVEN-ERIC JORDT
  • 依托单位:
海外基金